8 active trials 5 recruiting 2 Phase 3 4 disease areas
| Phase 2 | 3 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05417516 | A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2) | Breast Neoplasm Female | Recruiting | 2026-07-07 |
| NCT04228991 | Hypofractionated LocoRegional Radiotherapy in Breast Cancer | Breast Neoplasms | Active, Not Recruiting | 2026-06-17 |
| Phase 2 | ||||
| NCT06421675 | Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma | Refractory Multiple Myeloma | Recruiting | 2026-06-17 |
| NCT06654336 | Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy… | Prostate Adenocarcinoma | Recruiting | 2026-03-13 |
| NCT04090710 | SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer | Metastatic Renal Cell Carcinoma | Active, Not Recruiting | 2026-06-17 |
| Not specified | ||||
| NCT04797299 | Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in… | DCIS | Recruiting | 2026-08-14 |
| NCT05866458 | Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing… | Breast Cancer | Recruiting | 2026-06-17 |
| NCT01791829 | A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast… | Breast Cancer | Active, Not Recruiting | 2026-06-17 |
Breast Cancer (4) · Kidney Cancer (1) · Multiple Myeloma (1) · Prostate Cancer (1)